Health Condition 1: F172- Nicotine dependence
Conditions
Interventions
Intervention1: Yoga Group: Yoga intervention will be
performed online by the Yoga therapists of Centre for Integrative Medicine and Research (CIMR) at AIIMS, New Delhi. Along with the
standard medica
Sponsors
Centre for Integrative Medicine and Research CIMR
Eligibility
Inclusion criteria
Inclusion criteria: a) Smoking rate of at least 5 cigarettes/bidi per day or at least 5 times a day use of smokeless tobacco such as zarda (khani), gutka b) Adults between the age range of 18-65 years c) Willing and able to participate in 45 min of moderately intense exercise or yoga, d) No contraindications for moderate-intensity exercise based on the Physical Activity Readiness Questionnaire (Thomas, Reading, & Shephard, 1992)
Exclusion criteria
Exclusion criteria: a) Currently practicing regular exercise and yoga for more than 3 times per week. b) Currently enrolled in a quit-smoking program, c) Had a medical condition that might make participation in yoga difficult or potentially hazardous (e.g., heart failure NYHA Class III and Class IV, ischemia Class II, uncontrolled hypertension; COPD grade 3 and 4) d) Other substance abuse such as alcohol (more than 4 drinks on any day for men or more than 3 drinks for women; NIAAA, 2021)or opioid dependency e) Taking benzodiazepines, antidepressants, neuroleptics, anticonvulsants, or major tranquilizers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 7 Day Point Prevalence Abstinence validated by Salivary cotinineTimepoint: baseline and 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| self reported 7 days point prevalence abstinenceTimepoint: 2 (end of treatment), 3 and 6 months;self reported 30 days point prevalence abstinenceTimepoint: 2 (end of treatment), 3 and 6 months;smoke/smokeless percentage reductionTimepoint: baseline, 2 (end of treatment), 3 and 6 months;Depression Anxiety Stress Scale (DASS)Timepoint: baseline, 2 (end of treatment), 3 and 6 months;WHOQOL (BREF)Timepoint: baseline, 2 (end of treatment), 3 and 6 months;Smoking Situation Temptation ScaleTimepoint: baseline, 2 (end of treatment), 3 and 6 months;Smoking self-efficacy scaleTimepoint: baseline, 2 (end of treatment), 3 and 6 months;Withdrawal ScaleTimepoint: baseline, 2 (end of treatment), 3 and 6 months;Brief WISDM (-Wisconsin inventory of smoking dependence motives)Timepoint: baseline, 2 (end of treatment), 3 and 6 months;Fagerstrom Nicotine Dependence (FTND)Timepoint: Baseline, 2 (end of treatment), 3 and 6 months;Severson Smokeless Tobacco Dependence ScaleTimepoint: Baseline, 2 (end of treatment), 3 and 6 months | — |
Countries
India
Contacts
Public ContactGautam Sharma
All India Institute of Medical Sciences (AIIMS)
Outcome results
None listed